Moderna Inc

Change company Symbol lookup

Select an option...

MRNA Moderna Inc

LVS Las Vegas Sands Corp

PG Procter & Gamble Co

AMP Ameriprise Financial Inc

SPHD Invesco S&P 500® High Dividend Low Volatility ETF

MRK Merck & Co Inc

HD Home Depot Inc

SQM Sociedad Quimica y Minera de Chile SA

AVGO Broadcom Inc

O Realty Income Corp

Go

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.